Consolidated Statements of Cash Flows - USD ($)		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)		$ 2,276,000,000		$ (4,672,000,000)		$ 315,000,000
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Provision for (benefit from) deferred income taxes		606,000,000		(1,042,000,000)		47,000,000
Impairment of oil and natural gas properties		0		6,021,000,000		790,000,000
Depreciation, depletion, amortization and accretion		1,275,000,000		1,311,000,000		1,454,000,000
(Gain) loss on extinguishment of debt		75,000,000		5,000,000		56,000,000
(Gain) loss on derivative instruments, net		848,000,000		81,000,000		108,000,000
Cash received (paid) on settlement of derivative instruments		(1,247,000,000)		250,000,000		80,000,000
Equity-based compensation expense		51,000,000		37,000,000		48,000,000
(Gain) loss on sale of equity method investments		(23,000,000)		0		0
Other		47,000,000		30,000,000		8,000,000
Changes in operating assets and liabilities:
Accounts receivable		(196,000,000)		217,000,000		(187,000,000)
Income tax receivable		152,000,000		(62,000,000)		0
Prepaid expenses and other		20,000,000		2,000,000		29,000,000
Accounts payable and accrued liabilities		(41,000,000)		(20,000,000)		(129,000,000)
Revenues and royalties payable		148,000,000		(41,000,000)		135,000,000
Other		(47,000,000)		1,000,000		(15,000,000)
Net cash provided by (used in) operating activities		3,944,000,000		2,118,000,000		2,739,000,000
Cash flows from investing activities:
Drilling, completions and infrastructure additions to oil and natural gas properties		(1,457,000,000)		(1,719,000,000)		(2,677,000,000)
Additions to midstream assets		(30,000,000)		(140,000,000)		(244,000,000)
Property acquisitions		(812,000,000)		(185,000,000)		(776,000,000)
Proceeds from sale of assets		820,000,000		63,000,000		300,000,000
Contributions to equity method investments		(114,000,000)		(102,000,000)		(485,000,000)
Distributions from equity method investments		9,000,000		40,000,000		0
Other		45,000,000		(58,000,000)		(6,000,000)
Net cash provided by (used in) investing activities		(1,539,000,000)		(2,101,000,000)		(3,888,000,000)
Cash flows from financing activities:
Proceeds from borrowings under credit facilities		1,313,000,000		1,130,000,000		2,350,000,000
Repayments under credit facilities		(1,000,000,000)		(1,478,000,000)		(3,718,000,000)
Proceeds from senior notes		2,200,000,000		997,000,000		3,469,000,000
Repayment of senior notes		(3,193,000,000)		(239,000,000)		(1,250,000,000)
Proceeds from (repayments to) joint venture		(20,000,000)		40,000,000		39,000,000
Premium on extinguishment of debt		(178,000,000)		(2,000,000)		(44,000,000)
Public offering costs		0		0		(41,000,000)
Proceeds from public offerings		0		0		1,106,000,000
Repurchased shares under buyback program		(431,000,000)		(98,000,000)		(593,000,000)
Repurchased units under buyback program		(94,000,000)		(39,000,000)		0
Dividends to stockholders		(312,000,000)		(236,000,000)		(112,000,000)
Distributions to non-controlling interest		(112,000,000)		(93,000,000)		(122,000,000)
Financing portion of net cash received (paid) for derivative instruments		22,000,000		0		0
Other		(36,000,000)		(19,000,000)		(22,000,000)
Net cash provided by (used in) financing activities		(1,841,000,000)		(37,000,000)		1,062,000,000
Net increase (decrease) in cash and cash equivalents		564,000,000		(20,000,000)		(87,000,000)
Cash, cash equivalents and restricted cash at beginning of period		108,000,000	[1]	128,000,000	[1]	215,000,000
Cash, cash equivalents and restricted cash at end of period	[1]	$ 672,000,000		$ 108,000,000		$ 128,000,000

[1] See Note 2—Summary of Significant Accounting Policies